{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:44:55Z","timestamp":1759563895958},"reference-count":62,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":5626,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[1993,2]]},"abstract":"<jats:p><jats:bold>Summary: <\/jats:bold> Endometrial cancer is the commonest gynaecological cancer. Its relative increase in incidence over recent decades has been generally associated with a reduction in mortality. Evidence is presented to show a considerable variation in incidence worldwide; Australia, like England and Wales, has a comparatively low incidence. The incidence is highest in parts of the United States where it has shown an annual fall of nearly 3% between 1973 and 1987. The influence of hysterectomy, oral contraception and hormone replacement therapy at the menopause are discussed relative to incidence and prevention of the disease. Obesity and its prevention are also shown to have an influence on incidence and its ethnic variation worldwide. Despite a minor improvement in survival in FIGO published figures, the recent COSA\u2010UK\u2010NZ \u2018high risk\u2019 trial highlights the importance to the patient of closely monitored clinical trials.<\/jats:p>","DOI":"10.1111\/j.1479-828x.1993.tb02042.x","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T13:44:33Z","timestamp":1202910273000},"page":"1-7","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Endometrial Cancer: Trends in Incidence and Survival: A Preventable Disease?"],"prefix":"10.1111","volume":"33","author":[{"given":"B.L.G.","family":"Kneale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.G.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Cancer Statistics Review 1973\u201387","author":"National Cancer Institute","year":"1989"},{"key":"e_1_2_1_3_2","first-page":"1987","volume-title":"Cancer in Australia","author":"Giles GG","year":"1982"},{"key":"e_1_2_1_4_2","volume-title":"Cancer mortality trends in Australia Volume II 1910\u20131984","author":"Holman CDJ","year":"1987"},{"key":"e_1_2_1_5_2","volume-title":"Cancer Epidemiology and Prevention","author":"Waard F.","year":"1982"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(36)90035-2"},{"key":"e_1_2_1_7_2","first-page":"495","article-title":"Reducing cancer risk in women through lifestyle\u2010mediated changes in hormone levels","volume":"14","author":"Pike MC","year":"1991","journal-title":"Cancer detection and prevention"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00053128"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197606032942303"},{"key":"e_1_2_1_10_2","first-page":"246","article-title":"Estrogens as a cause of human cancer","volume":"48","author":"Henderson BE","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(91)90010-D"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(91)90004-Y"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490208"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490612"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198003063021004"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","unstructured":"BeralV HannaiordP KayC.Oral contraceplive use and malginancies of the genital tract.Lancet1988;1331\u20131335.","DOI":"10.1016\/S0140-6736(88)90869-0"},{"key":"e_1_2_1_17_2","volume-title":"Cancer risk and incidence trends: the Connecticut perspective","author":"Roush GC","year":"1987"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00117471"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197606032942304"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/oxfordjournals.aje.a114414","article-title":"Conjugated estrogen use and risk of endotnelrial cancer","volume":"124","author":"Buring JE","year":"1986","journal-title":"Am J Epidemiol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(87)90169-4"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1988.44"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1983.127"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9378(78)90287-9","article-title":"Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer","volume":"130","author":"McDonald PC","year":"1978","journal-title":"Amer J Obsiel Gynecol"},{"key":"e_1_2_1_25_2","first-page":"4360","article-title":"Steroid hormones and endomelrial cancer","volume":"38","author":"Siiteri PK","year":"1978","journal-title":"Cancer Res"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-43-2-272"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-196805000-00018"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500413"},{"key":"e_1_2_1_29_2","volume-title":"Cancer Incidence in Five Continents","author":"Muir C","year":"1987"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(91)90239-A"},{"key":"e_1_2_1_31_2","volume-title":"Mortality from cancer in migrants to Australia \u2010 1962 to 1971","author":"Armstrong BK","year":"1983"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910460214"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-85851-2"},{"key":"e_1_2_1_34_2","volume-title":"Cancer Incidence in Five Continents","author":"Waterhouse J","year":"1976"},{"key":"e_1_2_1_35_2","volume-title":"Cancer Incidence in Five Continents Vol IV","author":"Waterhouse J","year":"1982"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420505"},{"key":"e_1_2_1_37_2","volume-title":"Epidemiology of cancer in South Australia: incidence, mortality and survival 1977 to 1989, incidence and mortality 1989, analysed by type and geographical location","author":"Bonnett A","year":"1991"},{"key":"e_1_2_1_38_2","volume-title":"Cancer in Victoria 1982\u20131987","author":"Giles GG","year":"1992"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112402"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/19.2.255"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.32.3.175"},{"key":"e_1_2_1_42_2","first-page":"345","article-title":"Incidence of hysterectomy in New Zealand","volume":"100","author":"Macintosh MCM.","year":"1987","journal-title":"NZ Med J"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1978.tb131461.x"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.1988.tb00157.x"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1959.tb07185.x"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(74)90024-9"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1969.tb107629.x"},{"key":"e_1_2_1_48_2","unstructured":"KnealeBLG.Studies in the behaviour of cancer of the endometrium.Thesis Univ of Melb 1977."},{"key":"e_1_2_1_49_2","first-page":"789","article-title":"Adjunctive and therapeutic progestins in endometrial cancer","volume":"13","author":"Kneale BLG.","year":"1986","journal-title":"Clin Obs Gynaec"},{"key":"e_1_2_1_50_2","first-page":"765","article-title":"Mixed adeno\u2010squamous carcinoma of the endometrium","volume":"54","author":"Ng ABP","year":"1973","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197305)31:5<1127::AID-CNCR2820310514>3.0.CO;2-E"},{"key":"e_1_2_1_52_2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/ajcp\/77.5.534","article-title":"Carcinoma of the endometrium. II. Papillary adenocarcinoma: A clinical pathological study 46 cases","volume":"77","author":"Christopherson WM","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112149"},{"key":"e_1_2_1_54_2","unstructured":"CreasmanWTet al.The surgical pathological correlation in Stage 1 endometrial cancer. 10th ABB YAK meeting of the Society of Gynaecologic Oncologists 1979."},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0390599"},{"key":"e_1_2_1_56_2","first-page":"578","volume-title":"Gynaecologic Oncology","author":"Cohen CJ","year":"1981"},{"key":"e_1_2_1_57_2","volume-title":"A randomized controlled trial of medroxyprogesterone acetate (MPA) as adjuvant therapy for high risk (Group 3) endometrial cancer","author":"Kneale BLG","year":"1982"},{"key":"e_1_2_1_58_2","volume-title":"Carcinoma of the endometrium and management of the high risk patient","author":"Kneale BLG","year":"1982"},{"key":"e_1_2_1_59_2","volume-title":"Interim Clinical Analysis","author":"COSA\u2010UK\u2010NZ Endometrial Cancer National Committee Trial El\/82","year":"1990"},{"key":"e_1_2_1_60_2","volume-title":"Interim Clinical Analysis","author":"COSA\u2010UK\u2010NZ Endometrial Cancer National Committee Trial El\/82","year":"1986"},{"key":"e_1_2_1_61_2","volume-title":"Victorian Cooperative Oncology Group Newsletter","author":"Kneale BLG.","year":"1990"},{"key":"e_1_2_1_62_2","unstructured":"Annual Report on the results of treatment in gynaecological cancer Vol. 16.HLKottmeier(ed) International Federation of Gynaecology and Obstetrics Stockholm 1976."},{"key":"e_1_2_1_63_2","unstructured":"Annual Report on the results of treatment in gynaecological cancer. Vol. 20.FPettersson(ed) International Federation of Gynaecology and Obstetrics Stockholm 1988."}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1479-828X.1993.tb02042.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1479-828X.1993.tb02042.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T14:35:18Z","timestamp":1698244518000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1479-828X.1993.tb02042.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["10.1111\/j.1479-828X.1993.tb02042.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1479-828x.1993.tb02042.x","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,2]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}